Quince Therapeutics, Inc. (QNCX)

Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. CA

What they're doing

Between 2026-06-21 and 2026-09-19, public records show 3 signals for Quince Therapeutics, Inc.. Most notable: 2026-09-14: Filed 8-K disclosing acquisition or disposition of assets, director or officer change; 2026-07-31: Filed 8-K disclosing director or officer change; 2026-08-27: Filed 8-K disclosing director or officer change. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.

Generated 2026-09-19 from public records.

Signals, last 12 months

  1. Material 8-K filing
    Filed 8-K disclosing acquisition or disposition of assets, director or officer change
  2. Material 8-K filing
    Filed 8-K disclosing director or officer change
  3. Material 8-K filing
    Filed 8-K disclosing director or officer change
  4. Material 8-K filing
    Filed 8-K disclosing material agreement, acquisition or disposition of assets, director or officer change
  5. Material 8-K filing
    Filed 8-K disclosing director or officer change
  6. Material 8-K filing
    Filed 8-K disclosing director or officer change
  7. Material 8-K filing
    Filed 8-K disclosing material agreement

Insider transactions

DateInsiderRoleCodeSharesPriceValue
2025-12-26Benatti LucadirectorS50,0003.47$173,500
2025-12-10Thye DirkdirectorG739,8850$0
2025-12-10Thye DirkdirectorG739,8850$0
2025-12-05Hannah BrendanofficerM25,2800.94$23,763
2025-12-05Hannah BrendanofficerM2,2710.55$1,249
2025-06-18Hannah BrendanofficerA37,7361.2$45,283
2025-06-18Ryan Charles S.officerA7,5481.2$9,058
2025-06-18Thye DirkdirectorA150,9441.2$181,133
2024-10-23Benatti LucadirectorJ8,918——
2024-08-30Thye DirkdirectorP77,0000.7$53,900
2024-08-29Thye DirkdirectorP77,5000.69$53,475
2024-08-21Hannah BrendanofficerP5,0000.62$3,100
2024-08-21Hannah BrendanofficerP2,2800.61$1,391
2024-08-21Hannah BrendanofficerP23,5650.63$14,846
2024-08-20Hannah BrendanofficerP3,4240.6$2,054
2024-08-20Hannah BrendanofficerP2,5000.61$1,525
2024-08-20Ryan Charles S.officerP48,3870.65$31,452
2024-08-19Hannah BrendanofficerP2,1550.58$1,250

Federal contracts

No federal contract actions on record for this recipient mapping.

Lobbying

No federal lobbying filings on record for this client mapping.

Public attention

No Wikipedia pageview data linked to this company.

Recent filings